Biotech ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigatio – BLRX January 3, 2023
Biotech CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors January 3, 2023
Biotech CLASS ACTION UPDATE for EVA, EIGR and CURV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders January 3, 2023
Biotech MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm January 3, 2023
Biotech ASLAN Pharmaceuticals and Thermo Fisher Scientific Announce Partnership to Manufacture High Concentration Formulation of Eblasakimab for Future Studies January 3, 2023
Biotech ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action – EIGR January 2, 2023
Biotech 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm January 2, 2023
Biotech BLRX NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX January 1, 2023
Biotech EYEPOINT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options January 1, 2023
Search
life science
January 3, 2023
January 3, 2023
January 3, 2023
January 3, 2023
January 3, 2023
January 3, 2023
January 2, 2023
January 2, 2023
January 1, 2023
January 1, 2023
